Teva Debuts US Rituximab At A 10% Discount

Truxima Biosimilar Rival To Rituxan Is Licensed From Celltrion

 
• By David Wallace
10_Per_Cent
Teva has launched the Truxima rituximab biosimilar at a 10% discount to Rituxan • Source: Shutterstock

More from Biosimilars

More from Products